Epithalon (epithalon, Ala-Glu-Asp-Gly) is a short synthetic tetrapeptide created at the St. Petersburg Institute of Bioregulation and Gerontology on the basis of pineal extract. There is a lot of talk about "rejuvenation" around it, but this article is about something else: how the peptide behaves in the bottle. The editors analyzed what determines its stability, how a lyophilisate differs from a solution, and what storage errors turn the substance into an unpredictable mixture of decomposition products.
What exactly are we saving: tetrapeptide chemistry
Epithalon consists of only four amino acids - alanine, glutamic acid, aspartic acid and glycine. Its molecular weight is about 390 Da, meaning it is a very small molecule compared to proteins or even most peptide hormones. A short chain with no spatial structure means that there is no "assembly" of the molecule to disrupt, as in the case of proteins. However, this does not make the peptide invulnerable.
The main chemical weaknesses of epithalon are two acidic amino acids. The residue of aspartic acid is known in pharmaceutical chemistry as a "hot spot" of degradation: in an aqueous solution, it is able to form a cyclic succinimide intermediate product, from which isoaspartate forms and peptide bond cleavage occur. Asp-Gly sequences are especially prone to this, and this particular fragment is at the end of the epithalon molecule.
Another way of decay is the hydrolysis of peptide bonds, which is accelerated at neutral and alkaline pH and when heated. Unlike peptides with methionine, cysteine or tryptophan, epithalon is less sensitive to oxidation, so in its case temperature, water and time come to the fore.
For the person holding the vial, a simple conclusion follows: while the peptide is dry, chemical reactions proceed extremely slowly; as soon as water appears, the "clock" starts ticking much faster. All of the storage practices we describe below boil down to minimizing contact with water, heat, and repeated temperature changes.
Lyophilisate: storage conditions before opening
Epitalon is usually supplied as a lyophilisate, a white porous powder or "tablet" at the bottom of the vial. Lyophilization (freeze drying) removes water at low temperature and vacuum, and thanks to this, the peptide is able to be stored for a long time. The general principles of stability of peptide substances are described in classic reviews of pharmaceutical technology, in particular in the work of Manning et al.
For most research-grade lyophilized peptides, substance manufacturers recommend keeping sealed vials in a freezer (around −20 °C) for long-term storage and in a refrigerator (2–8 °C) for short-term storage. Room temperature for several days of transportation usually does not significantly harm the dry powder, but systematic storage in the heat shortens the shelf life.
Moisture is no less important. The lyophilisate is hygroscopic: an open cold bottle in a warm room is quickly covered with condensate, and part of the water gets inside. Therefore, the bottle taken out of the freezer should be allowed to warm up to room temperature, closed, and only then opened or punctured.
| Form | Typical conditions | The main threats | Comment |
|---|---|---|---|
| Lyophilisate, closed | −20 °C (long) or 2–8 °C | Moisture, heat, light | The most stable form |
| Lyophilisate during delivery | Room temperature did not last long | Overheating in transport | Avoid heat and direct sunlight |
| The reconstituted solution | 2–8 °C, in the dark | Hydrolysis, microbial contamination | The term is much shorter than that of the powder |
| Solution in the freezer | Preferably without aliquoting | Freeze-thaw cycles | Each cycle is additional stress |
Light is the third factor. Although epithalon does not contain particularly photosensitive amino acids, ultraviolet light accelerates the general degradation processes and can affect excipients. It is better to store the vials in the original box or in an opaque container, away from the refrigerator door, where the temperature fluctuates the most.
Powder recovery and solvent selection
"Dilution" in the context of peptides means reconstitution of the lyophilisate with a solvent. We deliberately do not consider the amount and concentration for human administration: epitalon is not registered as a medicine in the EU, USA or Ukraine, so there are no safe official recommendations for self-administration. Instead, let's focus on how the recovery process affects stability.
The most common diluents for peptides are sterile water for injection and bacteriostatic water containing 0.9% benzyl alcohol as a preservative. The first one does not suppress the growth of microorganisms, so the solution on it is actually disposable. The second allows the multidose vial to be stored longer, but benzyl alcohol has its own limitations: it is not used in newborns, and it causes reactions in some people.
- Sterility. The cork is wiped with alcohol and allowed to dry; do not touch the needle with your hands; the bottle is not opened completely.
- Softness. The solvent is directed along the wall of the bottle, not a jet onto the powder; the bottle is carefully rotated, but not shaken.
- Transparency. Properly reconstituted epithalon is well soluble in water and gives a clear, colorless solution without a precipitate.
- Marking. The date of recovery is applied to the bottle so as not to rely on memory.
Sometimes in the descriptions there is advice to dilute the peptides with physiological saline or even ordinary boiled water. The second is categorically unacceptable: a non-sterile liquid can introduce bacteria and endotoxins, and the injection of such a solution threatens with an abscess or systemic infection. Any manipulations with injection forms must comply with the principles of asepsis established, in particular, in the USP standard <797>.
What the solvent does not do is also important: it does not "activate" the peptide and does not increase its effect. Regeneration is only a transition from the most stable state to the less stable state, so it is wise to regenerate exactly as much as will be used within the short term.
Solution stability and standard errors
Unfortunately, there are no published independent studies of the stability of epithalon solutions in household conditions. Therefore, the editorial is based on general patterns for short peptides and on the principle of caution. The rate of chemical reactions roughly doubles or triples with every 10°C increase in temperature, so the difference between a refrigerator and a shelf in a room is fundamental.
The first typical mistake is repeated freezing of the solution. During freezing, the water crystallizes and the peptide and salts concentrate in unfrozen "pockets" where the pH and ionic strength change dramatically. For short peptides, this is less destructive than for proteins, but each cycle still adds degradation products. If the solution needs to be stored longer, in laboratory practice it is divided into aliquots that are thawed only once.
The second mistake is storing in the refrigerator door or near the back wall, where the product can freeze. The third is to leave the bottle on the table "for half an hour", which in practice turns into hours. The fourth is repeated punctures of the cork with a thick needle, due to which the tightness is broken over time and the risk of contamination increases.
Finally, it is worth remembering about the container. Peptides in very low concentrations can be partially adsorbed on the surface of glass and plastic, and syringes with silicone grease are not intended for long-term storage of the solution. Keeping reconstituted peptide in a stock syringe is a bad idea from both a stability and sterility perspective.
Signs of degradation and when it is better to dispose of the product
The worst thing about peptide degradation is that it is mostly invisible. Isoaspartate forms and hydrolysis products dissolve as well as the parent substance, and the solution remains clear. So "looks normal" doesn't mean "chemically intact." The only reliable way to estimate the content is laboratory analysis by HPLC with mass spectrometry.
However, there are visible signs that clearly indicate a problem. Turbidity, flakes, sediment, discoloration, gas bubbles, or an unusual odor indicate either contamination or the presence of foreign matter. Such a bottle should not be used in any case. The same applies to powder that has clumped together in a dense yellowish mass or "spread" on the walls - this is a sign of moisture or overheating.
Another signal is the inconsistency of documents. If there is no serial number, production date on the vial, and the certificate of analysis does not correspond to the batch, it is impossible to talk about guaranteed stability. We wrote more about quality control in a separate article.
Peptides and used needles should be disposed of as medical waste: needles — in a sharps container, vials — do not pour into water bodies. This also applies to the expired lyophilisate, even if it looks flawless from the outside.
Editorial conclusion
Epithalon is a short and relatively simple peptide, but its sequence contains a vulnerable fragment of Asp-Gly, prone to chemical transformations in water. The most stable form is a dry lyophilisate in the cold, dark and without contact with moisture.
The reconstituted solution lives much less, especially in sterile water without a preservative. Heat, repeated freezing, and aseptic breakdown are the main enemies of both peptide quality and human safety.
The transparency of the solution does not guarantee its integrity: invisible degradation is possible even in a "clean" bottle. That's why batch documentation and trust in the source are just as important as the right refrigerator.
If this topic is relevant to you, we recommend that you read our articles "How to distinguish quality Epitalon from fake" and "Epitalon status in the WADA list and legislation", as well as an overview of what is really known about the effects of epitalon on telomeres.
References
- Manning MC, Chou DK, Murphy BM, Payne RW, Katayama DS. Stability of protein pharmaceuticals: an update. Pharm Res. 2010;27(4):544â575.
- Khavinson VKh. Peptides and ageing. Neuro Endocrinol Lett. 2002;23 Suppl 3:11â144.
- Khavinson VKh, Bondarev IE, Butyugov AA. Epithalon peptide induces telomerase activity and telomere elongation in human somatic cells. Bull Exp Biol Med. 2003;135(6):590â592.
- International Council for Harmonisation. ICH Q1A(R2): Stability testing of new drug substances and products. 2003.
- United States Pharmacopeia. General Chapter <797> Pharmaceutical Compounding â Sterile Preparations. USP.
- Lau JL, Dunn MK. Therapeutic peptides: historical perspectives, current development trends, and future directions. Bioorg Med Chem. 2018;26(10):2700â2707.
